268 related articles for article (PubMed ID: 23063834)
1. Plasmodium liver load following parenteral sporozoite administration in rodents.
Ploemen IH; Chakravarty S; van Gemert GJ; Annoura T; Khan SM; Janse CJ; Hermsen CC; Hoffman SL; Sauerwein RW
Vaccine; 2013 Jul; 31(34):3410-6. PubMed ID: 23063834
[TBL] [Abstract][Full Text] [Related]
2. Intradermal immunization of mice with radiation-attenuated sporozoites of Plasmodium yoelii induces effective protective immunity.
Voza T; Kebaier C; Vanderberg JP
Malar J; 2010 Dec; 9():362. PubMed ID: 21159170
[TBL] [Abstract][Full Text] [Related]
3. Reduced Plasmodium berghei sporozoite liver load associates with low protective efficacy after intradermal immunization.
Nganou-Makamdop K; Ploemen I; Behet M; Van Gemert GJ; Hermsen C; Roestenberg M; Sauerwein RW
Parasite Immunol; 2012 Dec; 34(12):562-9. PubMed ID: 23171040
[TBL] [Abstract][Full Text] [Related]
4. Addition of histamine to subcutaneously injected Plasmodium berghei sporozoites increases the parasite liver load and could facilitate whole-parasite vaccination.
Pfeil J; Heine JF; Mueller AK
Malar J; 2015 Jan; 14():36. PubMed ID: 25627880
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy.
Leitner WW; Bergmann-Leitner ES; Angov E
Malar J; 2010 May; 9():145. PubMed ID: 20507620
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium yoelii-infected A. stephensi inefficiently transmit malaria compared to intravenous route.
Conteh S; Chattopadhyay R; Anderson C; Hoffman SL
PLoS One; 2010 Jan; 5(1):e8947. PubMed ID: 20126610
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.
Silvie O; Rubinstein E; Franetich JF; Prenant M; Belnoue E; Rénia L; Hannoun L; Eling W; Levy S; Boucheix C; Mazier D
Nat Med; 2003 Jan; 9(1):93-6. PubMed ID: 12483205
[TBL] [Abstract][Full Text] [Related]
8. Protective immunity differs between routes of administration of attenuated malaria parasites independent of parasite liver load.
Haeberlein S; Chevalley-Maurel S; Ozir-Fazalalikhan A; Koppejan H; Winkel BMF; Ramesar J; Khan SM; Sauerwein RW; Roestenberg M; Janse CJ; Smits HH; Franke-Fayard B
Sci Rep; 2017 Sep; 7(1):10372. PubMed ID: 28871201
[TBL] [Abstract][Full Text] [Related]
9. Parasite load stemming from immunization route determines the duration of liver-stage immunity.
Patel H; Althubaiti N; Parmar R; Yadav N; Joshi U; Tyagi RK; Krzych U; Dalai SK
Parasite Immunol; 2019 Jul; 41(7):e12622. PubMed ID: 30854655
[TBL] [Abstract][Full Text] [Related]
10. The intradermal route for inoculation of sporozoites of rodent malaria parasites for immunological studies.
Inoue M; Culleton RL
Parasite Immunol; 2011 Feb; 33(2):137-42. PubMed ID: 21226727
[TBL] [Abstract][Full Text] [Related]
11. Assessment of real-time method to detect liver parasite burden under different experimental conditions in mice infected with Plasmodium yoelii sporozoites.
Siddiqui AJ; Bhardwaj J; Goyal M; Prakash K; Soni A; Tiwari V; Puri SK
Microb Pathog; 2015 Dec; 89():35-42. PubMed ID: 26341953
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium yoelii sporozoite infectivity varies as a function of sporozoite loads in Anopheles stephensi mosquitoes.
Pumpuni CB; Mendis C; Beier JC
J Parasitol; 1997 Aug; 83(4):652-5. PubMed ID: 9267407
[TBL] [Abstract][Full Text] [Related]
13. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
14. Laser mimicking mosquito bites for skin delivery of malaria sporozoite vaccines.
Zhou C; Chen X; Zhang Q; Wang J; Wu MX
J Control Release; 2015 Apr; 204():30-7. PubMed ID: 25725360
[TBL] [Abstract][Full Text] [Related]
15. Clustering and Erratic Movement Patterns of Syringe-Injected versus Mosquito-Inoculated Malaria Sporozoites Underlie Decreased Infectivity.
de Korne CM; Winkel BMF; van Oosterom MN; Chevalley-Maurel S; Houwing HM; Sijtsma JC; Azargoshasb S; Baalbergen E; Franke-Fayard BMD; van Leeuwen FWB; Roestenberg M
mSphere; 2021 Apr; 6(2):. PubMed ID: 33827910
[TBL] [Abstract][Full Text] [Related]
16. Repetitive live sporozoites inoculation under arteether chemoprophylaxis confers protection against subsequent sporozoite challenge in rodent malaria model.
Bhardwaj J; Siddiqui AJ; Goyal M; Prakash K; Soni A; Puri SK
Acta Trop; 2016 Jun; 158():130-138. PubMed ID: 26925772
[TBL] [Abstract][Full Text] [Related]
17. Defining rules of CD8(+) T cell expansion against pre-erythrocytic Plasmodium antigens in sporozoite-immunized mice.
Billman ZP; Kas A; Stone BC; Murphy SC
Malar J; 2016 Apr; 15():238. PubMed ID: 27113469
[TBL] [Abstract][Full Text] [Related]
18. Noninfectious sporozoites in the salivary glands of a minimally susceptible anopheline mosquito.
Noden BH; Pumpuni CB; Vaughan JA; Beier JC
J Parasitol; 1995 Dec; 81(6):912-5. PubMed ID: 8544063
[TBL] [Abstract][Full Text] [Related]
19. A tracer-based method enables tracking of
Winkel BMF; de Korne CM; van Oosterom MN; Staphorst D; Bunschoten A; Langenberg MCC; Chevalley-Maurel SC; Janse CJ; Franke-Fayard B; van Leeuwen FWB; Roestenberg M
Theranostics; 2019; 9(10):2768-2778. PubMed ID: 31244921
[No Abstract] [Full Text] [Related]
20. Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum.
Sack BK; Miller JL; Vaughan AM; Douglass A; Kaushansky A; Mikolajczak S; Coppi A; Gonzalez-Aseguinolaza G; Tsuji M; Zavala F; Sinnis P; Kappe SH
Infect Immun; 2014 Feb; 82(2):808-17. PubMed ID: 24478094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
